Journal Article > LetterAbstract Only
Lancet HIV. 2024 October 1; Volume 11 (Issue 10); e711-e716.; DOI:10.1016/S2352-3018(24)00173-5
Venter WDF, Gandhi M, Sokhela S, Sikwese K, Bygrave H, et al.
Lancet HIV. 2024 October 1; Volume 11 (Issue 10); e711-e716.; DOI:10.1016/S2352-3018(24)00173-5
Journal Article > CommentaryFull Text
J Int AIDS Soc. 2016 December 1; Volume 19 (Issue 1); 21484.; DOI:10.7448/IAS.19.1.21484
Grimsrud A, Bygrave H, Doherty M, Ehrenkranz PD, Ellman T, et al.
J Int AIDS Soc. 2016 December 1; Volume 19 (Issue 1); 21484.; DOI:10.7448/IAS.19.1.21484
Journal Article > CommentaryFull Text
AIDS. 2015 July 16; Volume 29 (Issue 16); DOI:10.1097/QAD.0000000000000813
Cohn J, Bekker LG, Bygrave H, Calmy A
AIDS. 2015 July 16; Volume 29 (Issue 16); DOI:10.1097/QAD.0000000000000813
Journal Article > ReviewFull Text
Antivir Ther. 2014 October 13; Volume 19 (Issue Suppl 3); DOI:10.3851/IMP2905
Bekker LG, Venter F, Cohen K, Goemare E, van Cutsem G, et al.
Antivir Ther. 2014 October 13; Volume 19 (Issue Suppl 3); DOI:10.3851/IMP2905
Public sector antiretroviral provision had a slow start in South Africa despite a raging epidemic and a World AIDS conference that shed significant public light on the disparities of therapy access globally. This was largely due to political prevarication in the midst of AIDS denialism. There has been an unprecedented expansion in the HIV treatment programme since 2008. As a result, South Africa now has the largest number of patients on antiretroviral drugs in the world, and South African life expectancy has increased by more than a decade. However, this has led to a number of fiscal, logistic and operational challenges that the country must face as the treatment programme continues to expand. Challenges include increasing detection within communities, linkage and retention in care, while strengthening operational support functions such as consistent drug supply, health staffing and infrastructure, diagnostic services, programme monitoring and sustainable financing. As a middle-income country, albeit with marked income inequality, and the heaviest HIV burden in the world, South Africa is a test case of whether a large-scale public health programme can boast of success in the face of numerous other health-system challenges.